GH Research PLC (NASDAQ:GHRS - Get Free Report)'s stock price was down 0.3% on Friday . The stock traded as low as $8.60 and last traded at $9.25. Approximately 14,904 shares traded hands during trading, a decline of 81% from the average daily volume of 79,041 shares. The stock had previously closed at $9.28.
Analyst Ratings Changes
Several analysts have issued reports on GHRS shares. JMP Securities reissued a "market outperform" rating and issued a $39.00 price objective on shares of GH Research in a research note on Wednesday, September 4th. HC Wainwright reissued a "buy" rating and set a $40.00 price target on shares of GH Research in a research note on Wednesday, November 20th. Finally, Canaccord Genuity Group cut their price objective on GH Research from $31.00 to $28.00 and set a "buy" rating on the stock in a research report on Monday, November 18th.
View Our Latest Research Report on GHRS
GH Research Stock Down 3.8 %
The stock has a market cap of $464.63 million, a PE ratio of -11.30 and a beta of 0.74. The stock has a 50-day moving average of $8.01 and a 200 day moving average of $10.23.
GH Research (NASDAQ:GHRS - Get Free Report) last issued its quarterly earnings results on Tuesday, September 3rd. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.03. Research analysts forecast that GH Research PLC will post -0.79 EPS for the current fiscal year.
Institutional Trading of GH Research
An institutional investor recently raised its position in GH Research stock. Lynx1 Capital Management LP increased its position in GH Research PLC (NASDAQ:GHRS - Free Report) by 19.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,966,726 shares of the company's stock after buying an additional 656,163 shares during the period. GH Research comprises 16.7% of Lynx1 Capital Management LP's portfolio, making the stock its 3rd largest holding. Lynx1 Capital Management LP owned approximately 7.62% of GH Research worth $46,252,000 at the end of the most recent quarter. 56.90% of the stock is owned by hedge funds and other institutional investors.
About GH Research
(
Get Free Report)
GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).
Featured Articles
Before you consider GH Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GH Research wasn't on the list.
While GH Research currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
